RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 12-22
  • Valeant hikes its takeover offer for Allergan

    For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts. After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
  • Valeant again raises bid for Allergan

    Valeant again raises bid for Allergan
    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc.  The revised offer issued Friday now lifts the proposed deal value to about $53 billion, up from Wednesday's bid of...
  • Valeant raises offer for Allergan for 2nd time this week

    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc. The revised offer issued Friday lifts the proposed deal's value to about $53 billion, up from Wednesday's bid of about...
  • Ackman turns up heat on Allergan, calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting nastier. Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors....
  • Bid for Allergan turns hostile as Ackman calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting downright hostile — and even more bizarre. Activist investor Bill Ackman called for a special meeting at which Allergan shareholders could potentially vote out the bulk of the...
  • Costa Mesa recognizes its scholars

    Costa Mesa recognizes its scholars
    At the 35th annual Scholarship Recognition Breakfast on Friday morning in Costa Mesa, the student recipients' stories were varied, their successes exceptional. The banquet, hosted by the Costa Mesa Chamber of Commerce, took place at the Hilton Orange...
  • Commentary: Why residents want to 'draft Duffy' for City Council

    With no offense to Diane Dixon versus Michael Glenn, or Michael Toerge versus Scott Peotter, or even Tim Brown versus Roy Englebrecht, we may soon have a Newport Beach City Council race to watch. On Wednesday, the "Draft Duffy" movement will start with a...
  • Ackman warns Allergan on offer

    Activist investor Bill Ackman warned Botox maker Allergan Inc. on Monday that it would be unwise to court potential acquirers as an alternative to the offer that he and Valeant Pharmaceuticals International Inc. have made for the company. Last month,...
  • Allergan co-founder speaks out against Valeant takeover

    The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders. Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...
  • Botox-maker Allergan rejects takeover bid from Valeant

    Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders. Last month, the Irvine drugmaker received an...
  • Shire to acquire San Diego-based Lumena in more than $260 million deal

    Drug maker Shire is buying San Diego-based Lumena Pharmaceuticals for more than $260 million, a deal that expands the company's pipeline of rare disease treatments. The Irish company, producer of Adderall XR, plans to make a cash payment at the sale's...